Exclusive: Medikabazaar Is Raising INR 433 Cr From CDC Group, Existing Investors
India, Sept. 22 -- Mumbai-based B2B healthtech marketplace Medikabazaar is raising INR 433 Cr from a clutch of investors. UK-based CDC Group, Rebright Ventures are participating in this round of funding.
According to the regulatory filings accessed by Inc42, Medikabazaar is allotting 6,38,357 Series C Compulsory Convertible Preference Shares at a premium of INR 6787.22 to ten investors.
The new funding round which seems to be its Series C round will see participation of UK-based development finance institution CDC group which will be infusing a total of INR 131 Cr in exchange for 1,93,350 Series C CCPS.
Startup's existing investor Rebright Ventures will be pumping in INR 15 Cr and MSIVC Venture Capital will pump INR 30 Cr. Angel invest...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.